Boston, MA·Biotechnology, Healthcare, Pharmaceuticals·Last fund filed 2024
Funds on file
4
Partners named
4
4 on a current fund
Recent board seats
1
last 24 months
Capital raised
—
across filed funds
What has Bain Capital Life Sciences raised?
4 vehicles
Vehicle
Filed
Target
Sold to date
Investors
Bain Capital Life Sciences Fund IV, L.P.Filed to raise in 2024, with no closing reported yet.
2024
Indefinite
$0
0
Bain Capital Life Sciences Fund III, L.P.Filed to raise in 2021, with no closing reported yet.
2021
Indefinite
$0
0
Bain Capital Life Sciences Fund II, L.P.Filed to raise in 2019, with no closing reported yet.
2019
Indefinite
$0
0
Bain Capital Life Sciences Fund, L.P.Filed to raise in 2016, with no closing reported yet.
2016
Indefinite
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
Who at Bain Capital Life Sciences can lead a round?
4 named
4 partners are named across this firm’s filings, 4 of them on a fund it is deploying now.
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Fintech1 · 4%
Gaming & entertainment1 · 4%
Healthcare services1 · 4%
Medical devices1 · 4%
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Bain Capital Life Sciences’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
A shared board seat: a company where filings name a Bain Capital Life Sciences partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
